EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study

Anand Shah iD, Pranav Gwalani iD, Merry Zhai iD, Ritik Goyal iD, Joshua Kra iD

Thoracic Cancer · 2026-07 · 17 (14)

DOI: 10.1111/1759-7714.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 19.07.2026. Verfasst von Anand Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The optimal sequencing of brain‐directed radiation and systemic therapy in stage IV non–small cell lung cancer (NSCLC) with brain metastases remains uncertain in the era of CNS‐active systemic agents. We evaluated survival outcomes using national real‐world data.

Methods

We conducted a retrospective cohort study of adults diagnosed between 2010 and 2022 with stage IV NSCLC and brain metastases in the National Cancer Database who received both brain‐directed radiation and systemic therapy. Treatment sequence was classified as radiation‐first or systemic‐first based on initiation dates. Multivariable Cox proportional hazards models, stratified by treatment era (pre‐2015 vs. 2015+), assessed associations with overall survival (OS), adjusting for demographic, clinical, tumor, and treatment factors. Propensity score matching and delayed‐entry sensitivity analyses were performed to address confounding and immortal time bias.

Results

Among 45 577 patients, 78.3% received radiation‐first and 21.7% received systemic therapy first. Unadjusted Kaplan–Meier analysis showed no significant difference in OS (log‐rank p = 0.624). In multivariable analysis, systemic‐first sequencing was associated with a modest increase in mortality (adjusted hazard ratio [aHR] 1.06; 95% CI: 1.04–1.09), which was consistent in propensity‐matched (HR 1.07; 95% CI: 1.04–1.11) and delayed‐entry analyses (aHR 1.09; 95% CI: 1.07–1.12). The use of systemic‐first therapy increased over time. Established prognostic factors demonstrated larger effect sizes.

Conclusion

Systemic‐first sequencing was associated with a modest increase in adjusted mortality; however, the effect size was small relative to established prognostic factors and likely influenced by residual confounding and selection bias. These findings support individualized, multidisciplinary treatment decisions rather than a uniform sequencing strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCarcinoma, Non-Small-Cell LungLung NeoplasmsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingDatabases, FactualPrognosis

Autor:innen und Institutionen

  • Department of Medicine, Rutgers New Jersey Medical, Newark, New Jersey, USA.
  • Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Rutgers Cancer Institute, Newark, New Jersey, USA.

ORCID-Profile: Anand Shah, Pranav Gwalani, Merry Zhai, Ritik Goyal, Joshua Kra

Zitieren

APA

Shah, A., Gwalani, P., Zhai, M., Goyal, R., & Kra, J. (2026). Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study. Thoracic Cancer, 17(14). https://doi.org/10.1111/1759-7714.70359

Vancouver

Shah A, Gwalani P, Zhai M, Goyal R, Kra J. Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study. Thoracic Cancer. 2026;17(14). doi:10.1111/1759-7714.70359

BibTeX
@article{Shah2026,
  author = {Shah, Anand and Gwalani, Pranav and Zhai, Merry and Goyal, Ritik and Kra, Joshua},
  title = {Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study},
  journal = {Thoracic Cancer},
  year = {2026},
  volume = {17},
  number = {14},
  doi = {10.1111/1759-7714.70359}
}
Kostenlos starten →